Could Diabetes Increase The Likelihood of Cystic Macular Edema in Patients Treated with Paclitaxel?: A case report
Cystic Macular Edema and Paclitaxel
DOI:
https://doi.org/10.5281/zenodo.14579602Keywords:
Taxane, Diabetes, Cystic macular edema, Oncology, ToxicologyAbstract
A case of cystoid macular edema (CME) induced by paclitaxel in a diabetic patient. A 65-year-old female diagnosed with breast cancer presented with decreased vision in both eyes one week after cessation of paclitaxel. Ophthalmological examination revealed decreased visual acuity OU and asymmetrical CME with no signs of diabetic retinopathy. Optical coherence tomography and Fundus Fluorescein Angiography findings were consistent with Taxane-associated CME. Paclitaxel use in Diabetic patients might lead to increased susceptibility to Taxane-induced CME. Oncologists and Ophthalmologists should work closely to ensure early diagnosis and effective patient care.
References
Henderson IC, Berry DA, Demetri GD, et al. Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. J Clin Oncol. 2003;21(6):976-983. doi:10.1200/JCO.2003.02.063
Yokoe T, Fukada I, Kobayashi K, et al. Cystoid Macular Edema during Treatment with Paclitaxel and Bevacizumab in a Patient with Metastatic Breast Cancer: A Case Report and Literature Review. Case Rep Oncol. 2017;10(2):605-612. Published 2017 Jul 11. doi:10.1159/000477897
Burgos-Blasco B, Hernandez-Ruiz S, Lopez-Guajardo L, Donate-Lopez J. Dexamethasone intravitreal implant in cystoid macular edema secondary to paclitaxel therapy. Am J Ophthalmol Case Rep. 2020;18:100653. Published 2020 Mar 7. doi:10.1016/j.ajoc.2020.100653
Telander DG, Sarraf D. Cystoid macular edema with docetaxel chemotherapy and the fluid retention syndrome. Semin Ophthalmol. 2007;22(3):151-153. doi:10.1080/08820530701457373
Nakao S, Ikeda Y, Emi Y, Ishibashi T. Possibility of Müller Cell Dysfunction as the Pathogenesis of Paclitaxel Maculopathy. Ophthalmic Surg Lasers Imaging Retina. 2016;47(1):81-84. doi:10.3928/23258160-20151214-14
de la Morena Barrio P, Conesa MÁ, González-Billalabeitia E, et al. Delayed recovery and increased severity of Paclitaxel-induced peripheral neuropathy in patients with diabetes. J Natl Compr Canc Netw. 2015;13(4):417-423. doi:10.6004/jnccn.2015.0057
Wei WW, Yang XF, Gu H, Liu NP. Zhonghua Yan Ke Za Zhi. 2017;53(7):509-513. doi:10.3760/cma.j.issn.0412-4081.2017.07.007
Neriyanuri S, Pardhan S, Gella L, et al. Retinal sensitivity changes associated with diabetic neuropathy in the absence of diabetic retinopathy. Br J Ophthalmol. 2017;101(9):1174-1178. doi:10.1136/bjophthalmol-2016-309641
Forte R, Haulani H, Jürgens I. QUANTITATIVE AND QUALITATIVE ANALYSIS OF THE THREE CAPILLARY PLEXUSES AND CHORIOCAPILLARIS IN PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES MELLITUS WITHOUT CLINICAL SIGNS OF DIABETIC RETINOPATHY: A Prospective Pilot Study. Retina. 2020;40(2):333-344. doi:10.1097/IAE.0000000000002376
Kanakis M, Georgalas I, Makatsoris T, Pharmakakis N. Taxane Induced Cystoid Macular Edema: Case Report and Integrated Pathogenic Theory. Curr Drug Saf. 2019;14(1):43-47. doi:10.2174/1574886313666180828163016
Downloads
Published
How to Cite
License
Copyright (c) 2024 Nesime Setge Tıskaoğlu, Gizem Gürbostan Soysal, İlker Nihat Ökten
This work is licensed under a Creative Commons Attribution 4.0 International License.
